Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-06-19 MARCHIO ALBERT N II Chief Accounting & Adm Officer Grant or award · Stock Option (Right To Purchase) +83,334 83,334
2018-06-19 BARER SOL J Director Grant or award · Stock Option (Right To Purchase) +40,000 40,000
2018-06-19 Macdonald R. Loch Director Grant or award · Stock Option (Right To Purchase) +20,000 20,000
2018-06-19 Crane Rosemary A Director Grant or award · Stock Option (Right To Purchase) +20,000 20,000
2018-06-19 LOUGHLIN JAMES J Director Grant or award · Stock Option (Right To Purchase) +20,000 20,000
2018-06-19 Spiegel Robert J. Director Grant or award · Stock Option (Right To Purchase) +20,000 20,000
2018-06-19 Leuthner Brian A President and CEO Grant or award · Stock Option (Right To Purchase) +338,068 338,068
2018-06-19 Saik Andrew Chief Financial Officer Grant or award · Stock Option (Right To Purchase) +166,001 166,001
2018-06-19 Faleck Herbert J Chief Medical Officer Grant or award · Stock Option (Right To Purchase) +119,667 119,667
2018-06-19 MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary Grant or award · Stock Option (Right To Purchase) +99,534 99,534
2018-06-19 Wyant Alyssa SVP Regulatory Affairs Grant or award · Stock Option (Right To Purchase) +99,534 99,534
2018-03-23 Conti Kurt G Director Other disposition −58,476 0
2018-03-22 Macdonald R. Loch Chief Scientific Officer Sale −2,500 $16.41 $41K 570,602
2018-03-21 Macdonald R. Loch Chief Scientific Officer Sale −2,500 $16.52 $41K 573,102
2018-03-20 Macdonald R. Loch Chief Scientific Officer Sale −5,000 $16.47 $82K 575,602
2018-03-19 Macdonald R. Loch Chief Scientific Officer Sale −2,500 $16.66 $42K 580,602
2018-03-02 Leuthner Brian A President and CEO Sale −2,500 $15.08 $38K 70,236
2018-03-01 MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary Grant or award · Stock Option (Right To Purchase) +65,000 65,000
2018-03-01 Faleck Herbert J Chief Medical Officer Grant or award · Stock Option (Right To Purchase) +90,000 90,000
2018-03-01 BRENNAN DANIEL Chief Operating Officer Grant or award · Stock Option (Right To Purchase) +90,000 90,000

Page 9 of 18 · 346 trades